Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Director bought 25,000 shares at an average $2.41 ($60,350)
  4. 4 Open-market buy Director bought 5,000 shares at $2.40 ($12,000)
  5. 4 Exercise or conversion Chief Scientific Officer acquired 6,410 shares (option exercise)
  6. 4 Grant or award Chief Executive Officer acquired 662 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Executive VP, Research acquired 657 shares (grant or award)
  12. 4 Open-market buy Chief Financial Officer bought 50,000 shares at $2.85 ($142,250)
  13. 4 Open-market buy Director bought 30,000 shares at $3.29 ($98,700)
  14. 4 Open-market buy Chief Medical Officer bought 5,000 shares at $3.29 ($16,442)
  15. 4 Exercise or conversion Executive VP, Research acquired 3,700 shares (option exercise)
  16. 4 Exercise or conversion Chief Medical Officer acquired 7,881 shares (option exercise)
  17. 4 Open-market buy Director bought 1,371,362 shares at $2.99 ($4,100,372)
  18. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $2.88 ($28,800)
  19. 4 Open-market sale General Counsel sold 2,614 shares at $2.69 ($7,032)
  20. 4 Grant or award Chief Medical Officer acquired 11,699 shares (grant or award)

Page 7 of 11 · 211 filings